Global Allergy Diagnostics Market Size, Share, Trends & Growth Analysis Report 2026-2034

Description

The Allergy Diagnostics Market size is expected to reach USD 17.19 Billion in 2034 from USD 6.41 Billion (2025) growing at a CAGR of 11.58% during 2026-2034.

The Global Allergy Diagnostics market has witnessed steady growth due to rising prevalence of allergic conditions worldwide. Increasing urbanization and environmental pollution have contributed to higher allergy incidence. Improved awareness and access to diagnostic testing have significantly supported market expansion. Growing healthcare infrastructure further strengthens demand.

Key growth drivers include advancements in in vitro diagnostic technologies and point-of-care testing solutions. Early detection enables effective treatment planning and management. Rising pediatric and geriatric populations also contribute to increased testing demand. Additionally, expanding healthcare expenditure supports adoption in developing economies.

Future prospects remain promising as personalized medicine gains traction. Development of multiplex testing platforms will enhance efficiency and accuracy. Growing awareness campaigns about allergy prevention will boost diagnostic rates. The market is expected to experience consistent growth driven by healthcare advancements.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

Consumables
Instruments
Services

By Test Type

In Vivo Tests
In Vitro Tests

By Allergen

Inhaled Allergens
Food Allergens
Drug Allergens
Other Allergens

By End User

Hospitals-Based Laboratories & Clinics
Diagnostic Laboratories
Academic Research Institutes

COMPANIES PROFILED

Thermo Fisher Scientific Inc, Siemens Healthineers AG, Danaher, Canon Inc, Minaris Medical America Inc, Eurofins Scientific, Euroimmun Medizinische Labordiagnostika Ag, bioMrieux SA, Stallergenes Greer Ltd, HollisterStier Allergy, Omega Diagnostics Group PLC
We can customise the report as per your requirements.

Product Code: VMR11211531

Chapter 1. PREFACE

1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis

Chapter 4. GLOBAL ALLERGY DIAGNOSTICS MARKET: BY TYPE 2022-2034 (USD MN)

4.1. Market Analysis, Insights and Forecast Type
4.2. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ALLERGY DIAGNOSTICS MARKET: BY TEST TYPE 2022-2034 (USD MN)

5.1. Market Analysis, Insights and Forecast Test Type
5.2. In Vivo Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. In Vitro Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ALLERGY DIAGNOSTICS MARKET: BY ALLERGEN 2022-2034 (USD MN)

6.1. Market Analysis, Insights and Forecast Allergen
6.2. Inhaled Allergens Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.3. Food Allergens Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.4. Drug Allergens Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.5. Other Allergens Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ALLERGY DIAGNOSTICS MARKET: BY END USER 2022-2034 (USD MN)

7.1. Market Analysis, Insights and Forecast End User
7.2. Hospitals-Based Laboratories & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.4. Academic Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL ALLERGY DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

8.1. Regional Outlook
8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.2.1 By Type
- 8.2.2 By Test Type
- 8.2.3 By Allergen
- 8.2.4 By End User
- 8.2.5 United States
- 8.2.6 Canada
- 8.2.7 Mexico
8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.3.1 By Type
- 8.3.2 By Test Type
- 8.3.3 By Allergen
- 8.3.4 By End User
- 8.3.5 United Kingdom
- 8.3.6 France
- 8.3.7 Germany
- 8.3.8 Italy
- 8.3.9 Russia
- 8.3.10 Rest Of Europe
8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.4.1 By Type
- 8.4.2 By Test Type
- 8.4.3 By Allergen
- 8.4.4 By End User
- 8.4.5 India
- 8.4.6 Japan
- 8.4.7 South Korea
- 8.4.8 Australia
- 8.4.9 South East Asia
- 8.4.10 Rest Of Asia Pacific
8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.5.1 By Type
- 8.5.2 By Test Type
- 8.5.3 By Allergen
- 8.5.4 By End User
- 8.5.5 Brazil
- 8.5.6 Argentina
- 8.5.7 Peru
- 8.5.8 Chile
- 8.5.9 South East Asia
- 8.5.10 Rest of Latin America
8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.6.1 By Type
- 8.6.2 By Test Type
- 8.6.3 By Allergen
- 8.6.4 By End User
- 8.6.5 Saudi Arabia
- 8.6.6 UAE
- 8.6.7 Israel
- 8.6.8 South Africa
- 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

9.1. Recent Developments
9.2. Company Categorization
9.3. Supply Chain & Channel Partners (based on availability)
9.4. Market Share & Positioning Analysis (based on availability)
9.5. Vendor Landscape (based on availability)
9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL ALLERGY DIAGNOSTICS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Company Profiles
- 10.2.1 Thermo Fisher Scientific Inc
- 10.2.2 Siemens Healthineers AG
- 10.2.3 Danaher
- 10.2.4 Canon Inc
- 10.2.5 Minaris Medical America Inc
- 10.2.6 Eurofins Scientific
- 10.2.7 Euroimmun Medizinische Labordiagnostika Ag
- 10.2.8 BioMAfA(C)Rieux SA
- 10.2.9 Stallergenes Greer Ltd
- 10.2.10 HollisterStier Allergy
- 10.2.11 Omega Diagnostics Group PLC